The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides

Journal of Drug Targeting

Volumn 19, Issue 8, 2011, Pages 675-680

  Fei, Likun ^a   Ren, Ling ^a   Zaro, Jennica L ^a   Shen, Wei Chiang ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Arginine rich peptide; Cell penetrating peptide; Clustered arginine residues; Intracellular distribution; Positive charge

Indexed keywords

ARGININE; CELL PENETRATING PEPTIDE; GLUTAMIC ACID; GLYCINE;

ANIMAL CELL; ARTICLE; BINDING AND RELATED PHENOMENA; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CYTOSOL; DRUG DELIVERY SYSTEM; DRUG TARGETING; INTERNALIZATION; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SURFACE BINDING;

ANIMALS; ARGININE; CELL CULTURE TECHNIQUES; CELL FRACTIONATION; CELL-PENETRATING PEPTIDES; CERCOPITHECUS AETHIOPS; CHO CELLS; CRICETINAE; CYTOSOL; DRUG CARRIERS; ENDOCYTOSIS; IODINE RADIOISOTOPES; PROTEIN BINDING; SURFACE PROPERTIES;

EID: 80051727049     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.531729     Document Type: Article

References (32)

1. Barnes MP, Shen WC. (2009). Disulfde and thioether linked cytochrome c-oligoarginine conjugates in HeLa cells. Int J Pharm, 369, 79-84.
2. Cahill K. (2010). Molecular electroporation and the transduction of oligoarginines. Phys Biol, 7, article number 016001.
3. El-Andaloussi S, Järver P, Johansson HJ, Langel U. (2007). Cargo-dependent cytotoxicity and delivery efcacy of cell-penetrating peptides: a comparative study. Biochem J, 407, 285-292. (Pubitemid 47556993)
4. Fischer PM. (2007). Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001-2006. Med Res Rev, 27, 755-795. (Pubitemid 350035119)
5. Fischer R, Waizenegger T, Köhler K, Brock R. (2002). A quantitative validation of fuorophore-labelled cell-permeable peptide conjugates: fuorophore and cargo dependence of import. Biochim Biophys Acta, 1564, 365-374.
6. Gelman RA, Blackwell J. (1973). Heparin-polypeptide interactions in aqueous solution. Arch Biochem Biophys, 159, 427-433.
7. Lee HL, Dubikovskaya EA, Hwang H, Semyonov AN, Wang H, Jones LR, Twieg RJ, Moerner WE, Wender PA. (2008). Single-molecule motions of oligoarginine transporter conjugates on the plasma membrane of Chinese hamster ovary cells. J Am Chem Soc, 130, 9364-9370. (Pubitemid 352031145)
8. Lundberg M, Johansson M. (2001). Is VP22 nuclear homing an artifact? Nat Biotechnol, 19, 713-714.
9. Melikov K, Chernomordik LV. (2005). Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery. Cell Mol Life Sci, 62, 2739-2749. (Pubitemid 41779944)
10. Mueller J, Kretzschmar I, Volkmer R, Boisguerin P. (2008). Comparison of cellular uptake using 22 CPPs in 4 diferent cell lines. Bioconjug Chem, 19, 2363-2374.
11. Nakase I, Niwa M, Takeuchi T, Sonomura K, Kawabata N, Koike Y, Takehashi M, Tanaka S, Ueda K, Simpson JC, Jones AT, Sugiura Y, Futaki S. (2004). Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ter, 10, 1011-1022. (Pubitemid 39625245)
12. Patel LN, Wang J, Kim KJ, Borok Z, Crandall ED, Shen WC. (2009). Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin. Mol Pharm, 6, 492-503.
13. Patel LN, Zaro JL, Shen WC. (2007). Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res, 24, 1977-1992. (Pubitemid 47493563)
14. Richard JP, Melikov K, Brooks H, Prevot P, Lebleu B, Chernomordik LV. (2005). Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem, 280, 15300-15306. (Pubitemid 40562886)
15. Rothbard JB, Kreider E, VanDeusen CL, Wright L, Wylie BL, Wender PA. (2002). Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J Med Chem, 45, 3612-3618. (Pubitemid 34856101)
16. Rothbard JB, Jessop TC, Lewis RS, Murray BA, Wender PA. (2004). Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J Am Chem Soc, 126, 9506-9507. (Pubitemid 39031015)
17. Sawant R, Torchilin V. (2010). Intracellular transduction using cell-penetrating peptides. Mol Biosyst, 6, 628-640.
18. Schmidt N, Mishra A, Lai GH, Wong GC. (2010). Arginine-rich cell-penetrating peptides. FEBS Lett, 584, 1806-1813.
19. Shen WC, Wan J, Ekrami H. (1992). Enhancement of polypeptide and protein absorption by macromolecular carriers via endocytosis and transcytosis. Adv Drug Deliv Rev, 8, 93-113.
20. Sonoda S, Schlamowitz M. (1970). Studies of 125I trace labeling of immunoglobulin G by chloramine-T. Immunochemistry, 7, 885-898.
21. Ter-Avetisyan G, Tünnemann G, Nowak D, Nitschke M, Herrmann A, Drab M, Cardoso MC. (2009). Cell entry of arginine-rich peptides is independent of endocytosis. J Biol Chem, 284, 3370-3378.
22. Torén PE, Persson D, Isakson P, Goksör M, Onfelt A, Nordén B. (2003). Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem Biophys Res Commun, 307, 100-107.
23. Tung CH, Weissleder R. (2003). Arginine containing peptides as delivery vectors. Adv Drug Deliv Rev, 55, 281-294. (Pubitemid 36135919)
24. Tünnemann G, Martin RM, Haupt S, Patsch C, Edenhofer F, Cardoso MC. (2006). Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J, 20, 1775-1784. (Pubitemid 44933791)
25. Vivès E, Schmidt J, Pèlegrin A. (2008). Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta, 1786, 126-138.
26. Wender PA, Galliher WC, Goun EA, Jones LR, Pillow TH. (2008). Te design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliv Rev, 60, 452-472.
27. Widera A, Norouziyan F, Shen WC. (2003). Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery. Adv Drug Deliv Rev, 55, 1439-1466. (Pubitemid 37464572)
28. Zaro JL, Shen WC. (2003). Quantitative comparison of membrane transduction and endocytosis of oligopeptides. Biochem Biophys Res Commun, 307, 241-247. (Pubitemid 36818860)
29. Zaro JL, Shen WC. (2005a). Evidence that membrane transduction of oligoarginine does not require vesicle formation. Exp Cell Res, 307, 164-173. (Pubitemid 40732742)
30. Zaro JL, Shen WC. (2005b). Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cells. J Control Release, 108, 409-417. (Pubitemid 41608672)
31. Zaro JL, Rajapaksa TE, Okamoto CT, Shen WC. (2006). Membrane transduction of oligoarginine in HeLa cells is not mediated by macropinocytosis. Mol Pharm, 3, 181-186. (Pubitemid 43672254)
32. Zhang X, Jin Y, Plummer MR, Pooyan S, Gunaseelan S, Sinko PJ. (2009). Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide. Mol Pharm, 6, 836-848.